Search

1 to 10 of 142
Sort by

Library Entry
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a systematic assessment of the cost-effectiveness (CE) of ICIs. Authors: Vivek Verma , Tanja Sprave , Waqar Haque , Charles B. Simone II , Joe Y. Chang , James W. Welsh and Charles R. Thomas Jr. JITC(2018) 1:128 ...



Library Entry
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report about adverse skeletal effects of immunotherapy, a phenomenon not previously described. Authors: Kendall F. Moseley , Jarushka Naidoo , Clifton O. Bingham , Michael A. Carducci , Patrick M. Forde , ...


Library Entry
Immunotherapy for the Treatment of Genitourinary Cancers: Patient Resource Guide

Published in partnership with the Society for Immunotherapy of Cancer (SITC), the Immunotherapy for the Treatment of Genitourinary Cancers: Patient Resource Guide provides current, medically accurate information intended specifically for patients and their caregivers. Immunotherapy for the...

ImmunotherapyforGenitourinaryCancers.pdf


Library Entry
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that aims to summarize nivolumab-related serious adverse events (SAEs) and fatal adverse events (FAEs) and to estimate the incidence and risk of SAEs/FAEs by conducting a meta-analysis among adult patients with...


Library Entry
2018 Advances in Cancer Immunotherapy™ - Boston, MA

2018 Advances in Cancer Immunotherapy TM - Boston, MA September 27, 2018 Wyndham Boston Beacon Hill Program Organizers Elizabeth Buchbinder, MD - Dana-Farber Cancer Institute David F. McDermott, MD - Beth Israel Deaconess Medical Center Virginia Seery, MSN, RN, ANP-BC - Beth Israel...

17 attachments


Library Entry
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on the first durable systemic treatment of malignant epithelioid angiomyolipoima with the use of PD-1 antibody nivolumab. Authors: Michael Lattanzi , Fang-Ming Deng , Luis A. Chiriboga , Alisa N. Femia , Shane...


Library Entry
Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article about open-label, first-in-human, phase 1 study evaluated the safety, pharmacokinetics, pharmacodynamics, and maximum tolerated dose (MTD) of AMG 228, an agonistic human IgG1 monoclonal antibody targeting...